SCHEMBL19465129

SCHEMBL19465129

CNCC(=O)C(Cc1ccccc1)NC(=O)C(N)Cc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.58
HDAC4 P56524 1/20 0.58
HDAC1 Q13547 1/20 0.58
HDAC7 Q8WUI4 1/20 0.58
HDAC2 Q92769 1/20 0.58
HDAC10 Q969S8 1/20 0.58
HDAC11 Q96DB2 1/20 0.58
HDAC8 Q9BY41 1/20 0.58
HDAC6 Q9UBN7 1/20 0.58
HDAC9 Q9UKV0 1/20 0.58
HDAC5 Q9UQL6 1/20 0.58
CTSC P53634 2/20 0.53
OPRD1 P41143 5/20 0.51
OPRM1 P35372 4/20 0.51
OPRK1 P41145 2/20 0.51
SLC15A1 P46059 1/20 0.50
ALPI P09923 1/20 0.49
PKM P14618 1/20 0.49
PTGS1 P23219 1/20 0.49
XIAP P98170 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18506593 0.86 CTSC (0.56) HDAC3HDAC4HDAC1HDAC2HDAC8
SCHEMBL20669159 0.84 MMP1 (0.61) CTSC
SCHEMBL12202126 0.84 CTSC (0.60) CTSCOPRD1OPRM1OPRK1SLC15A1
SCHEMBL7410429 0.84 HDAC3 (0.65) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL7410433 0.84 HDAC3 (0.65) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL7694204 0.84 SLC15A1 (0.60) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL19465132 0.84 SLC15A1 (0.60) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL1329567 0.82 MME (0.67) CTSCALPIPKMPTGS1XIAP
SCHEMBL5065345 0.82 MME (0.67) CTSCALPIPKMPTGS1XIAP
SCHEMBL825577 0.82 MME (0.67) CTSCALPIPKMPTGS1XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11021706-B2 Antisense antibacterial compounds and methods BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2021-06-01 US disclosed
US-10907158-B2 Antisense antibacterial compounds and methods BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2021-02-02 US disclosed
US-20200032254-A1 ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS OREGON STATE UNIVERSITY 2020-01-30 US disclosed
US-10391098-B2 Antisense antibacterial compounds and methods BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2019-08-27 US disclosed
US-20190078095-A1 ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2019-03-14 US disclosed
US-9790495-B2 Antisense antibacterial compounds and methods OREGON STATE UNIVERSITY (US) 2017-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190078095-A1 ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS FBL, RNGTT, ZFR HDAC3 1992/4885HDAC4 1701/4885HDAC1 1911/4885
US-10907158-B2 Antisense antibacterial compounds and methods FBL, RNGTT, ZFR HDAC3 1992/4885HDAC4 1701/4885HDAC1 1911/4885
US-11021706-B2 Antisense antibacterial compounds and methods RNGTT, ZFR, UPF1 HDAC3 1660/4885HDAC4 1433/4885HDAC1 2144/4885
US-10391098-B2 Antisense antibacterial compounds and methods RNGTT, POLRMT, POLM HDAC3 2369/4885HDAC4 1256/4885HDAC1 1810/4885
US-20200032254-A1 ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS RNGTT, ZFR, UPF1 HDAC3 1660/4885HDAC4 1433/4885HDAC1 2144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.